✦ LIBER ✦

Pharmacoeconomics of Alzheimer’s disease (AD) treatment with cholinesterase inhibitors

✍ Scribed by Versijpt, Jan

Book ID: 113111946
Publisher: Royal Association of Belgian Medical Scientific Societies
Year: 2012
Tongue: English
Weight: 176 KB
Volume: 112
Category: Article
ISSN: 0300-9009
DOI: 10.1007/s13760-012-0062-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced Alzheimer's diseas

Treatment of advanced Alzheimer's disease with cholinesterase inhibitors

✍ Amos D. Korczyn 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Defining optimal treatment with cholines

Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease

✍ Gary Small; Roger Bullock 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 811 KB

Cholinesterase Inhibitors in the Treatme

Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

✍ Professor Agneta Nordberg, Anne-Lie Svensson 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 207 KB

Cholinesterase Inhibitors Used in the Tr

Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease

✍ Dr David G. Wilkinson, Paul T. Francis, Elias Schwam… 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 232 KB

CHOLINESTERASE INHIBITOR TREATMENT AND U

CHOLINESTERASE INHIBITOR TREATMENT AND URINARY INCONTINENCE IN ALZHEIMER'S DISEASE

✍ John M. Starr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Initiating and monitoring cholinesterase

Initiating and monitoring cholinesterase inhibitor treatment for Alzheimer's disease

✍ Gregory R. J. Swanwick; Brian A. Lawlor 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

The availability of acetylcholinesterase inhibitors for the treatment of Alzheimer's disease raises a number of clinical and ethical questions. Many of the guidelines published in an attempt to tackle these questions lack either clinical or scienti®c validity. Against this background a model is prop